Budapest, Hungary

Zsolt Komlodi


Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zsolt Komlodi: Innovator in Dopamine Ligands

Introduction

Zsolt Komlodi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmacology, particularly in the development of dopamine ligands. With a total of 2 patents to his name, his work focuses on innovative solutions for medical treatments.

Latest Patents

Zsolt's latest patents involve new dopamine D and D ligands of a specific formula. These ligands are characterized by the presence of R1, R2, and Q, as described in his patent documentation. The inventions also encompass geometric isomers, stereoisomers, diastereomers, salts, hydrates, solvates, and polymorphs. Furthermore, the patents detail processes for preparing these compounds, compositions containing them, and their applications in treating conditions that require modulation of dopamine receptors.

Career Highlights

Zsolt Komlodi is associated with Richter Gedeon Nyrt., a prominent pharmaceutical company. His work there has allowed him to focus on groundbreaking research and development in the field of dopamine-related treatments. His contributions have the potential to impact various medical conditions significantly.

Collaborations

Zsolt has collaborated with several professionals in his field, including Gizella Bartane Szalai and Eva Againe Csongor. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Zsolt Komlodi stands out as an influential inventor in the realm of dopamine ligands. His patents and work at Richter Gedeon Nyrt. reflect his commitment to advancing medical science. His contributions are poised to make a lasting impact on the treatment of conditions related to dopamine receptors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…